1. 273PD_PRFinal analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients. (23rd October 2018) Authors: Reinisch, M; Seiler, S; Hauzenberger, T; Schmatloch, S; Strittmatter, H-J; Zahm, D-M; Thode, C; Jackisch, C; Strik, D; Moebus, V; Reimer, T; Sinn, B; Stickeler, E; Marme, F; Janni, W; Kamischke, A; Rudlowski, C; Nekljudova, V; von Minckwitz, G; Loibl, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 282TiPReal-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study. (23rd October 2018) Authors: Fasching, P A; Decker, T; Guderian, G; Heim, J; Jackisch, C; Lueck, H-J; Lüftner, D; Marmé, F; Reimer, T; Woeckel, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial. Issue 3 (23rd January 2021) Authors: Hartmann, S; Kühn, T; de Boniface, J; Stachs, A; Winckelmann, A; Frisell, J; Wiklander-Bråkenhielm, I; Stubert, J; Gerber, B; Reimer, T Journal: British journal of surgery Issue: Volume 108:Issue 3(2021) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗